EXPE Expedia Group | $337.97 -0.3% | 8/25/2026 | | Boost Price Target | $350.00 ➝ $400.00 | Buy | 00.00% | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 8/25/2026 |
MXCT MaxCyte | $1.35 -2.9% | 8/24/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for BTIG Research rating of MaxCyte (NASDAQ:MXCT) on 8/24/2026 |
ATRC AtriCure | $48.68 -1.2% | 8/24/2026 | | Boost Price Target | $45.00 ➝ $55.00 | Buy | 00.00% | View details for BTIG Research rating of AtriCure (NASDAQ:ATRC) on 8/24/2026 |
CRM Salesforce | $205.74 -1.6% | 8/24/2026 | | Reiterated Rating | $255.00 | Buy | 00.00% | View details for BTIG Research rating of Salesforce (NYSE:CRM) on 8/24/2026 |
IOND Ionic Digital | $70.00 +0.7% | 8/24/2026 | | Initiated Coverage | $85.00 | Buy | 00.00% | View details for BTIG Research rating of Ionic Digital (NASDAQ:IOND) on 8/24/2026 |
JMKE Jersey Mike's | $22.18 -5.7% | 8/24/2026 | | Initiated Coverage | $28.00 | Buy | 00.00% | View details for BTIG Research rating of Jersey Mike’s (NYSE:JMKE) on 8/24/2026 |
REF Reformation | $13.35 -7.8% | 8/24/2026 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for BTIG Research rating of Reformation (NYSE:REF) on 8/24/2026 |
ZM Zoom Communications | $100.92 -3.7% | 8/24/2026 | | Reiterated Rating | $125.00 | Buy | 00.00% | View details for BTIG Research rating of Zoom Communications (NASDAQ:ZM) on 8/24/2026 |
AAPG Ascentage Pharma Group International | $16.95 +1.4% | 8/21/2026 | | Reiterated Rating | $48.00 | Buy | 00.00% | View details for BTIG Research rating of Ascentage Pharma Group International (NASDAQ:AAPG) on 8/21/2026 |
MDXH MDxHealth | $0.79 +6.4% | 8/21/2026 | | Lower Price Target | $4.00 ➝ $2.00 | Buy | 00.00% | View details for BTIG Research rating of MDxHealth (NASDAQ:MDXH) on 8/21/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
RVLV Revolve Group | $23.38 -2.4% | 8/21/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 8/21/2026 |
WMT Walmart | $105.38 -1.0% | 8/21/2026 | | Lower Price Target | $145.00 ➝ $140.00 | Buy | 00.00% | View details for BTIG Research rating of Walmart (NASDAQ:WMT) on 8/21/2026 |
HYPR Hyperfine | $0.87 +1.6% | 8/20/2026 | | Reiterated Rating | $2.00 | Buy | 00.00% | View details for BTIG Research rating of Hyperfine (NASDAQ:HYPR) on 8/20/2026 |
LWAY Lifeway Foods | $26.16 -0.6% | 8/20/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for BTIG Research rating of Lifeway Foods (NASDAQ:LWAY) on 8/20/2026 |
ACIU AC Immune | $2.92 +2.1% | 8/20/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for BTIG Research rating of AC Immune (NASDAQ:ACIU) on 8/20/2026 |
BILL BILL | $47.67 -1.0% | 8/20/2026 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for BTIG Research rating of BILL (NYSE:BILL) on 8/20/2026 |
GKOS Glaukos | $181.48 -2.2% | 8/20/2026 | | Boost Price Target | $193.00 ➝ $202.00 | Buy | 00.00% | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 8/20/2026 |
KIDS OrthoPediatrics | $24.50 -2.3% | 8/20/2026 | | Boost Price Target | $24.00 ➝ $29.00 | Buy | 00.00% | View details for BTIG Research rating of OrthoPediatrics (NASDAQ:KIDS) on 8/20/2026 |
LNSR LENSAR | $8.94 -3.1% | 8/20/2026 | | Boost Price Target | $9.00 ➝ $10.00 | Buy | 00.00% | View details for BTIG Research rating of LENSAR (NASDAQ:LNSR) on 8/20/2026 |
LWAY Lifeway Foods | $26.16 -0.6% | 8/20/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for BTIG Research rating of Lifeway Foods (NASDAQ:LWAY) on 8/20/2026 |
TEM Tempus AI | $68.73 +3.9% | 8/20/2026 | | Boost Price Target | $70.00 ➝ $80.00 | Buy | 00.00% | View details for BTIG Research rating of Tempus AI (NASDAQ:TEM) on 8/20/2026 |
TJX TJX Companies | $139.54 -0.8% | 8/20/2026 | | Reiterated Rating | $190.00 | Buy | 00.00% | View details for BTIG Research rating of TJX Companies (NYSE:TJX) on 8/20/2026 |
RCEL Avita Medical | $10.50 +6.0% | 8/19/2026 | | Boost Price Target | $7.00 ➝ $11.00 | Buy | 00.00% | View details for BTIG Research rating of Avita Medical (NASDAQ:RCEL) on 8/19/2026 |
GEHC GE HealthCare Technologies | $73.91 -0.4% | 8/19/2026 | | Reiterated Rating | $79.00 | Buy | 00.00% | View details for BTIG Research rating of GE HealthCare Technologies (NASDAQ:GEHC) on 8/19/2026 |
HSIC Henry Schein | $89.65 +0.2% | 8/19/2026 | | Boost Price Target | $100.00 ➝ $110.00 | Buy | 00.00% | View details for BTIG Research rating of Henry Schein (NASDAQ:HSIC) on 8/19/2026 |
LFST LifeStance Health Group | $12.28 +1.0% | 8/19/2026 | | Boost Price Target | $16.00 ➝ $18.00 | Buy | 00.00% | View details for BTIG Research rating of LifeStance Health Group (NASDAQ:LFST) on 8/19/2026 |
RAPP Rapport Therapeutics | $51.17 +3.7% | 8/19/2026 | | Reiterated Rating | $65.00 | Buy | 00.00% | View details for BTIG Research rating of Rapport Therapeutics (NASDAQ:RAPP) on 8/19/2026 |
CVNA Carvana | $75.78 +4.8% | 8/18/2026 | | Reiterated Rating | $87.00 | Buy | 00.00% | View details for BTIG Research rating of Carvana (NYSE:CVNA) on 8/18/2026 |
CBLL CeriBell | $23.95 +0.0% | 8/18/2026 | | Boost Price Target | $28.00 ➝ $30.00 | Buy | 00.00% | View details for BTIG Research rating of CeriBell (NASDAQ:CBLL) on 8/18/2026 |
HAE Haemonetics | $108.35 0.0% | 8/18/2026 | | Boost Price Target | $96.00 ➝ $110.00 | Buy | 00.00% | View details for BTIG Research rating of Haemonetics (NYSE:HAE) on 8/18/2026 |
MDT Medtronic | $91.23 -1.8% | 8/18/2026 | | Reiterated Rating | $91.00 | Buy | 00.00% | View details for BTIG Research rating of Medtronic (NYSE:MDT) on 8/18/2026 |
NRXP NRx Pharmaceuticals | $3.67 +6.4% | 8/18/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for BTIG Research rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 8/18/2026 |
AAPL Apple | $309.90 -0.1% | 8/17/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for BTIG Research rating of Apple (NASDAQ:AAPL) on 8/17/2026 |
ADT ADT | $7.45 +0.3% | 8/17/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for BTIG Research rating of ADT (NYSE:ADT) on 8/17/2026 |
FRNM Freenome | $13.99 +1.5% | 8/17/2026 | | Initiated Coverage | $17.00 | Buy | 00.00% | View details for BTIG Research rating of Freenome (NASDAQ:FRNM) on 8/17/2026 |
DRUG Bright Minds Biosciences | $79.49 +3.2% | 8/17/2026 | | Reiterated Rating | $147.00 | Buy | 00.00% | View details for BTIG Research rating of Bright Minds Biosciences (NASDAQ:DRUG) on 8/17/2026 |
FRNM Freenome | $13.99 +1.5% | 8/17/2026 | | Initiated Coverage | $17.00 | Buy | 00.00% | View details for BTIG Research rating of Freenome (NASDAQ:FRNM) on 8/17/2026 |
LUCD Lucid Diagnostics | $1.01 +1.0% | 8/17/2026 | | Reiterated Rating | $2.50 | Buy | 00.00% | View details for BTIG Research rating of Lucid Diagnostics (NASDAQ:LUCD) on 8/17/2026 |
WDAY Workday | $194.42 -2.4% | 8/17/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for BTIG Research rating of Workday (NASDAQ:WDAY) on 8/17/2026 |
WRBY Warby Parker | $25.91 -1.1% | 8/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 8/14/2026 |
Someone just dumped the biggest gold fund. (Ad) Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing total outflows to 14 billion.
At the same time, the World Gold Council recorded the highest quarterly central bank gold buying on record, with buyers taking physical delivery instead of paper shares. Discover the company on the buying side before the September 30th delivery date. |
BRZE Braze | $30.80 -2.0% | 8/14/2026 | | Boost Price Target | $30.00 ➝ $35.00 | Buy | 00.00% | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 8/14/2026 |
MH McGraw Hill | $13.07 -5.1% | 8/14/2026 | | Lower Price Target | $19.00 ➝ $17.00 | Buy | 00.00% | View details for BTIG Research rating of McGraw Hill (NYSE:MH) on 8/14/2026 |
MSGE Madison Square Garden Entertainment | $80.96 +1.7% | 8/14/2026 | | Boost Price Target | $86.00 ➝ $100.00 | Buy | 00.00% | View details for BTIG Research rating of Madison Square Garden Entertainment (NYSE:MSGE) on 8/14/2026 |
TPR Tapestry | $130.08 -1.6% | 8/14/2026 | | Lower Price Target | $180.00 ➝ $175.00 | Buy | 00.00% | View details for BTIG Research rating of Tapestry (NYSE:TPR) on 8/14/2026 |
KTB Kontoor Brands | $79.70 -4.2% | 8/14/2026 | | Boost Price Target | $100.00 ➝ $105.00 | Buy | 00.00% | View details for BTIG Research rating of Kontoor Brands (NYSE:KTB) on 8/14/2026 |
BIRK Birkenstock | $35.19 -0.3% | 8/14/2026 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 8/14/2026 |
GLNG Golar LNG | $52.04 +1.2% | 8/14/2026 | | Boost Price Target | $67.00 ➝ $70.00 | Buy | 00.00% | View details for BTIG Research rating of Golar LNG (NASDAQ:GLNG) on 8/14/2026 |
LGN LGN | $57.26 +1.6% | 8/14/2026 | | Reiterated Rating | $120.00 ➝ $100.00 | Buy | 00.00% | View details for BTIG Research rating of LGN (NASDAQ:LGN) on 8/14/2026 |
NOMD Nomad Foods | $11.89 -1.7% | 8/14/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for BTIG Research rating of Nomad Foods (NYSE:NOMD) on 8/14/2026 |
OTLK Oncobiologics | $0.64 +5.1% | 8/14/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for BTIG Research rating of Oncobiologics (NASDAQ:OTLK) on 8/14/2026 |
ANRO Alto Neuroscience | $36.20 -0.1% | 8/13/2026 | | Boost Price Target | $28.00 ➝ $37.00 | Buy | 00.00% | View details for BTIG Research rating of Alto Neuroscience (NYSE:ANRO) on 8/13/2026 |
AVBP ArriVent BioPharma | $31.35 +10.9% | 8/13/2026 | | Reiterated Rating | $42.00 | Buy | 00.00% | View details for BTIG Research rating of ArriVent BioPharma (NASDAQ:AVBP) on 8/13/2026 |
BETA BETA Technologies | $22.17 -7.0% | 8/13/2026 | | Reiterated Rating | $33.00 | Buy | 00.00% | View details for BTIG Research rating of BETA Technologies (NYSE:BETA) on 8/13/2026 |
BTSG BrightSpring Health Services | $57.23 -3.8% | 8/13/2026 | | Reiterated Rating | $90.00 | Buy | 00.00% | View details for BTIG Research rating of BrightSpring Health Services (NASDAQ:BTSG) on 8/13/2026 |
ENS Enersys | $194.38 +3.7% | 8/13/2026 | | Reiterated Rating | $280.00 | Buy | 00.00% | View details for BTIG Research rating of Enersys (NYSE:ENS) on 8/13/2026 |
LFTO Liftoff Mobile | $18.70 -2.4% | 8/13/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for BTIG Research rating of Liftoff Mobile (NASDAQ:LFTO) on 8/13/2026 |
LNSR LENSAR | $8.94 -3.1% | 8/13/2026 | | Boost Price Target | $7.00 ➝ $9.00 | Buy | 00.00% | View details for BTIG Research rating of LENSAR (NASDAQ:LNSR) on 8/13/2026 |
SBC SBC Medical Group | $4.25 +2.4% | 8/13/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for BTIG Research rating of SBC Medical Group (NASDAQ:SBC) on 8/13/2026 |
HUMA Humacyte | $0.70 +5.9% | 8/12/2026 | | Reiterated Rating | $2.00 | Buy | 00.00% | View details for BTIG Research rating of Humacyte (NASDAQ:HUMA) on 8/12/2026 |
ABSI Absci | $9.63 +8.9% | 8/12/2026 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for BTIG Research rating of Absci (NASDAQ:ABSI) on 8/12/2026 |
AMTM Amentum | $20.31 +1.2% | 8/12/2026 | | Lower Price Target | $35.00 ➝ $30.00 | Buy | 00.00% | View details for BTIG Research rating of Amentum (NYSE:AMTM) on 8/12/2026 |
APGE Apogee Therapeutics | $134.85 +0.0% | 8/12/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for BTIG Research rating of Apogee Therapeutics (NASDAQ:APGE) on 8/12/2026 |
APP AppLovin | $310.54 +4.0% | 8/12/2026 | | Lower Price Target | $574.00 ➝ $408.00 | Buy | 00.00% | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 8/12/2026 |
BCAX Bicara Therapeutics | $24.58 +4.2% | 8/12/2026 | | Boost Price Target | $28.00 ➝ $39.00 | Buy | 00.00% | View details for BTIG Research rating of Bicara Therapeutics (NASDAQ:BCAX) on 8/12/2026 |
BWAY Brainsway | $14.43 +1.7% | 8/12/2026 | | Boost Price Target | $18.00 ➝ $20.00 | Buy | 00.00% | View details for BTIG Research rating of Brainsway (NASDAQ:BWAY) on 8/12/2026 |
IPHA Innate Pharma | $2.27 +3.2% | 8/12/2026 | | Boost Price Target | $8.00 ➝ $9.00 | Buy | 00.00% | View details for BTIG Research rating of Innate Pharma (NASDAQ:IPHA) on 8/12/2026 |
LQDA Liquidia | $70.49 +0.3% | 8/12/2026 | | Boost Price Target | $109.00 ➝ $111.00 | Buy | 00.00% | View details for BTIG Research rating of Liquidia (NASDAQ:LQDA) on 8/12/2026 |
MAZE Maze Therapeutics | $30.42 +2.8% | 8/12/2026 | | Reiterated Rating | $46.00 | Buy | 00.00% | View details for BTIG Research rating of Maze Therapeutics (NASDAQ:MAZE) on 8/12/2026 |
MNPR Monopar Therapeutics | $110.82 -0.5% | 8/12/2026 | | Boost Price Target | $117.00 ➝ $133.00 | Buy | 00.00% | View details for BTIG Research rating of Monopar Therapeutics (NASDAQ:MNPR) on 8/12/2026 |
MOBI Mobia Medical | $10.63 -3.2% | 8/12/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for BTIG Research rating of Mobia Medical (NASDAQ:MOBI) on 8/12/2026 |
NEXN Nexxen International | $10.17 +1.7% | 8/12/2026 | | Boost Price Target | $10.00 ➝ $13.00 | Buy | 00.00% | View details for BTIG Research rating of Nexxen International (NASDAQ:NEXN) on 8/12/2026 |
TE T1 Energy | $4.64 +7.4% | 8/12/2026 | | Boost Price Target | $8.00 ➝ $9.00 | Buy | 00.00% | View details for BTIG Research rating of T1 Energy (NYSE:TE) on 8/12/2026 |
WYFI WhiteFiber | $20.40 -1.8% | 8/12/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for BTIG Research rating of WhiteFiber (NASDAQ:WYFI) on 8/12/2026 |
TKNO Alpha Teknova | $7.46 +1.6% | 8/11/2026 | | Upgrade | $8.00 | Neutral ➝ Buy | 00.00% | View details for BTIG Research rating of Alpha Teknova (NASDAQ:TKNO) on 8/11/2026 |
ALC Alcon | $73.34 -0.5% | 8/11/2026 | | Reiterated Rating | $82.00 | Buy | 00.00% | View details for BTIG Research rating of Alcon (NYSE:ALC) on 8/11/2026 |
CBLL CeriBell | $23.95 +0.0% | 8/11/2026 | | Reiterated Rating | $28.00 | Buy | 00.00% | View details for BTIG Research rating of CeriBell (NASDAQ:CBLL) on 8/11/2026 |
GANX Gain Therapeutics | $1.90 -5.0% | 8/11/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for BTIG Research rating of Gain Therapeutics (NASDAQ:GANX) on 8/11/2026 |
HROW Harrow | $41.33 +3.8% | 8/11/2026 | | Reiterated Rating | $63.00 | Buy | 00.00% | View details for BTIG Research rating of Harrow (NASDAQ:HROW) on 8/11/2026 |
MMSI Merit Medical Systems | $91.09 +0.9% | 8/11/2026 | | Reiterated Rating | $105.00 | Buy | 00.00% | View details for BTIG Research rating of Merit Medical Systems (NASDAQ:MMSI) on 8/11/2026 |
MREO Mereo BioPharma Group | $0.28 -2.7% | 8/11/2026 | | Reiterated Rating | $1.00 | Buy | 00.00% | View details for BTIG Research rating of Mereo BioPharma Group (NASDAQ:MREO) on 8/11/2026 |
ONON ON | $28.82 -2.3% | 8/11/2026 | | Lower Price Target | $70.00 ➝ $60.00 | Buy | 00.00% | View details for BTIG Research rating of ON (NYSE:ONON) on 8/11/2026 |
ORKA Oruka Therapeutics | $101.82 -0.6% | 8/11/2026 | | Reiterated Rating | $151.00 | Buy | 00.00% | View details for BTIG Research rating of Oruka Therapeutics (NASDAQ:ORKA) on 8/11/2026 |
STIM Neuronetics | $2.98 +3.1% | 8/11/2026 | | Boost Price Target | $5.00 ➝ $6.00 | Buy | 00.00% | View details for BTIG Research rating of Neuronetics (NASDAQ:STIM) on 8/11/2026 |
SYRE Spyre Therapeutics | $107.36 +0.7% | 8/11/2026 | | Boost Price Target | $112.00 ➝ $132.00 | Buy | 00.00% | View details for BTIG Research rating of Spyre Therapeutics (NASDAQ:SYRE) on 8/11/2026 |
TCMD Tactile Systems Technology | $23.58 +0.9% | 8/11/2026 | | Lower Price Target | $40.00 ➝ $39.00 | Buy | 00.00% | View details for BTIG Research rating of Tactile Systems Technology (NASDAQ:TCMD) on 8/11/2026 |
TPB Turning Point Brands | $86.07 +3.1% | 8/10/2026 | | Reiterated Rating | | Buy | 00.00% | View details for BTIG Research rating of Turning Point Brands (NYSE:TPB) on 8/10/2026 |
TTWO Take-Two Interactive Software | $232.93 -0.2% | 8/10/2026 | | Boost Price Target | $293.00 ➝ $313.00 | Buy | 00.00% | View details for BTIG Research rating of Take-Two Interactive Software (NASDAQ:TTWO) on 8/10/2026 |
OMDA Omada Health | $23.94 -0.6% | 8/10/2026 | | Boost Price Target | $30.00 ➝ $35.00 | Buy | 00.00% | View details for BTIG Research rating of Omada Health (NASDAQ:OMDA) on 8/10/2026 |
BETR Better Home & Finance | $12.30 +4.9% | 8/10/2026 | | Lower Price Target | $36.00 ➝ $23.00 | Buy | 00.00% | View details for BTIG Research rating of Better Home & Finance (NASDAQ:BETR) on 8/10/2026 |
CCSI Consensus Cloud Solutions | $38.95 +0.6% | 8/10/2026 | | Boost Price Target | $45.00 ➝ $50.00 | Buy | 00.00% | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 8/10/2026 |
Trump’s New Currency Reset (Ad) Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. Watch the documentary briefing and find out which side you land on |
HWM Howmet Aerospace | $264.17 +0.3% | 8/10/2026 | | Boost Price Target | $300.00 ➝ $340.00 | Buy | 00.00% | View details for BTIG Research rating of Howmet Aerospace (NYSE:HWM) on 8/10/2026 |
JBIO Jade Biosciences | $21.84 +2.4% | 8/10/2026 | | Boost Price Target | $74.00 ➝ $77.00 | Buy | 00.00% | View details for BTIG Research rating of Jade Biosciences (NASDAQ:JBIO) on 8/10/2026 |
MNDY monday.com | $93.23 -1.1% | 8/10/2026 | | Reiterated Rating | $105.00 | Buy | 00.00% | View details for BTIG Research rating of monday.com (NASDAQ:MNDY) on 8/10/2026 |
NESR National Energy Services Reunited | $33.48 +0.2% | 8/10/2026 | | Boost Price Target | $32.00 ➝ $40.00 | Buy | 00.00% | View details for BTIG Research rating of National Energy Services Reunited (NASDAQ:NESR) on 8/10/2026 |
SION Sionna Therapeutics | $6.25 +11.8% | 8/10/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for BTIG Research rating of Sionna Therapeutics (NASDAQ:SION) on 8/10/2026 |
RL Ralph Lauren | $363.11 -2.1% | 8/7/2026 | | Boost Price Target | $450.00 ➝ $460.00 | Buy | 00.00% | View details for BTIG Research rating of Ralph Lauren (NYSE:RL) on 8/7/2026 |
NTRA Natera | $336.71 +2.7% | 8/7/2026 | | Boost Price Target | $290.00 ➝ $320.00 | Buy | 00.00% | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 8/7/2026 |
CARG CarGurus | $36.45 -2.0% | 8/7/2026 | | Boost Price Target | $40.00 ➝ $41.00 | Buy | 00.00% | View details for BTIG Research rating of CarGurus (NASDAQ:CARG) on 8/7/2026 |
ICUI ICU Medical | $182.24 -0.2% | 8/7/2026 | | Boost Price Target | $170.00 ➝ $200.00 | Buy | 00.00% | View details for BTIG Research rating of ICU Medical (NASDAQ:ICUI) on 8/7/2026 |
TEAM Atlassian | $166.49 -2.8% | 8/7/2026 | | Boost Price Target | $130.00 ➝ $180.00 | Buy | 00.00% | View details for BTIG Research rating of Atlassian (NASDAQ:TEAM) on 8/7/2026 |